On behalf of the Conference Organizing Committee, it is with great pleasure that we welcome you to the official website of the 3rd International Conference on Neurological Disorders and Brain Injury during April 17-18, 2017 at London, UK We would like to formally invite you to join us at our upcoming 3rd International Conference on Neurological Disorders and Brain Injury during April 17- 18, 2017 at London, UK. We would like to organize this c...

Pediatric Pathology 2017 will be an innovative and invigorating International conference reflecting the direction of Pediatric Pathology in the 21st century in a secure yet exciting environment that offers a wide range of diversions to participants of all backgrounds. This conference provides an excellent opportunity to discuss the latest developments within the field. Pediatric Pathology 2017 focuses around the theme “Clinical Advanceme...

We look forward to welcoming you all at the upcoming "2nd International Conference on Adolescent Medicine and Child Psychology to be held from October 6-7, 2016 at Crowne Plaza, London, UK" a leading forum for Psychiatrist, Doctors, healthcare professionals, researchers and students. We are truly honored to welcome world-renowned faculty to Innovate, Educate & Invigorate our attendees. The main theme of the conference is “New Insight...

Patient safety is the biggest single issue in the NHS and UK healthcare. After a year of unprecedented focus on patient safety, 2014 is the start of the next stage in the journey to eradicate avoidable harm and deliver improved outcomes. The legacy of the Francis report (and the government’s formal response) into Mid Staffordshire, the Keogh review into trusts with unusually high mortality rates and the Berwick review on behalf of the Pr...

New EU requirements are expected to come into force during 2014, impacting clinical trial processes including informed consent as well as the provision of public access to information and results of clinical trials. This workshop will review the new transparency requirements and voluntary commitments and, describe how these will impact current disclosure procedures. There will be a focus on sharing experiences on how the requirements are being...

SMi Group have worked closely with an expert speaker panel which includes KOLs from Amal Therapeutics, Amgen, DanDrit Biotech, CureVac and Vaccinogen, to put together an exciting conference agenda for the 3rd annual Cancer Vaccines conference taking place on 15th and 16th September in London UK. This year's program will feature a mix of case study led presentations, networking opportunities, an interactive workshop and keynote addresses that h...

The responsibilities for all stakeholders involved are set out in GVP Module XVI for Risk Minimisation . It is important to ensure that additional risk minimisation measures, including assessment of their effectiveness, do not introduce undue burden on the healthcare delivery system, the marketing authorisation holders, the regulators, and, most importantly, on the patients. The necessity to have a clearly defined objective in order to minimis...

This two day event is designed to enhance SMis portfolio of pharmaceutical conferences, especially with a growing demand for biologic therapeutics. We ask the questions: What stimulates an immune response? How does the system cope with immunogenic compounds? And how do you screen for potential problems? The Conference will address all these concerns and enable Clinical Immunologists, Physicians and Specialists within the field of Immunogenicit...

Join SMi's Emergence of antimicrobial resistance in 2014 and how to stop it event on the 10 July in London, To understand the current thinking in antimicrobial chemotherapy and the global changesAntimicrobial resistance is perceived as an increasing threat to health and well-being globally. This is not a new message – it is one that has been repeated many times over the past three decades. What is new today and is the problem reaching a...

Over the next six years, the global mHealth market will continue to make a mark in a serious way, with the industry poised to exceed $49.1 billion by 2020, according to a new market report. According to research conducted by San Francisco-based market analysis and Grand View Research, monitoring services are projected to remain the dominant and most rapidly growing market segment, with revenue topping $1.2 billion in 2012, and seeing a nearly...